These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Human immunodeficiency virus pathogenesis and prospects for immune control in patients with established infection. Cohen DE; Walker BD Clin Infect Dis; 2001 Jun; 32(12):1756-68. PubMed ID: 11360218 [TBL] [Abstract][Full Text] [Related]
6. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection. Altfeld M; Rosenberg ES; Shankarappa R; Mukherjee JS; Hecht FM; Eldridge RL; Addo MM; Poon SH; Phillips MN; Robbins GK; Sax PE; Boswell S; Kahn JO; Brander C; Goulder PJ; Levy JA; Mullins JI; Walker BD J Exp Med; 2001 Jan; 193(2):169-80. PubMed ID: 11148221 [TBL] [Abstract][Full Text] [Related]
7. Early induction and maintenance of Env-specific T-helper cells following human immunodeficiency virus type 1 infection. Malhotra U; Holte S; Zhu T; Delpit E; Huntsberry C; Sette A; Shankarappa R; Maenza J; Corey L; McElrath MJ J Virol; 2003 Feb; 77(4):2663-74. PubMed ID: 12552005 [TBL] [Abstract][Full Text] [Related]
8. Cellular immune response to human immunodeficiency virus. Norris PJ; Rosenberg ES AIDS; 2001 Feb; 15 Suppl 2():S16-21. PubMed ID: 11424972 [TBL] [Abstract][Full Text] [Related]
9. Early and persistent human immunodeficiency virus type 1 (HIV-1)-specific T helper dysfunction in blood and lymph nodes following acute HIV-1 infection. Musey LK; Krieger JN; Hughes JP; Schacker TW; Corey L; McElrath MJ J Infect Dis; 1999 Aug; 180(2):278-84. PubMed ID: 10395840 [TBL] [Abstract][Full Text] [Related]
10. Immune control of HIV-1 after early treatment of acute infection. Rosenberg ES; Altfeld M; Poon SH; Phillips MN; Wilkes BM; Eldridge RL; Robbins GK; D'Aquila RT; Goulder PJ; Walker BD Nature; 2000 Sep; 407(6803):523-6. PubMed ID: 11029005 [TBL] [Abstract][Full Text] [Related]
11. CD4 responses to conserved HIV-1 T helper epitopes show both negative and positive associations with virus load in chronically infected subjects. Boaz MJ; Waters A; Murad S; Easterbrook PJ; D'Sousa E; van Wheeley C; Vyakarnam A Clin Exp Immunol; 2003 Dec; 134(3):454-63. PubMed ID: 14632751 [TBL] [Abstract][Full Text] [Related]
12. Correlates of antiviral immune restoration in acute and chronic HIV type 1 infection: sustained viral suppression and normalization of T cell subsets. Dyer WB; Kuipers H; Coolen MW; Geczy AF; Forrester J; Workman C; Sullivan JS AIDS Res Hum Retroviruses; 2002 Sep; 18(14):999-1010. PubMed ID: 12396452 [TBL] [Abstract][Full Text] [Related]
13. HIV-specific immunity during structured antiviral drug treatment interruption. Moss RB; Brandt C; Giermakowska WK; Savary JR; Theofan G; Zanetti M; Carlo DJ; Wallace MR Vaccine; 2003 Mar; 21(11-12):1066-71. PubMed ID: 12559781 [TBL] [Abstract][Full Text] [Related]
14. Comparison of human immunodeficiency virus (HIV)-specific T-cell responses in HIV-1- and HIV-2-infected individuals in Senegal. Zheng NN; Kiviat NB; Sow PS; Hawes SE; Wilson A; Diallo-Agne H; Critchlow CW; Gottlieb GS; Musey L; McElrath MJ J Virol; 2004 Dec; 78(24):13934-42. PubMed ID: 15564501 [TBL] [Abstract][Full Text] [Related]
15. CTL escape and increased viremia irrespective of HIV-specific CD4+ T-helper responses in two HIV-infected individuals. Geels MJ; Jansen CA; Baan E; De Cuyper IM; van Schijndel GJ; Schuitemaker H; Goudsmit J; Pollakis G; Miedema F; Paxton WA; van Baarle D Virology; 2006 Feb; 345(1):209-19. PubMed ID: 16246391 [TBL] [Abstract][Full Text] [Related]
16. Characterization of HIV-specific proliferative T cell responses in HIV-infected persons. Zhang Y; Huber M; Weissbrich B; Voss G; Langmann P; Klinker H; Jassoy C AIDS Res Hum Retroviruses; 2001 May; 17(7):623-9. PubMed ID: 11375058 [TBL] [Abstract][Full Text] [Related]
17. HIV type 1-specific helper T cells: a critical host defense. Rosenberg ES; Walker BD AIDS Res Hum Retroviruses; 1998 Jun; 14 Suppl 2():S143-7. PubMed ID: 9672231 [No Abstract] [Full Text] [Related]
18. Viremia control despite escape from a rapid and potent autologous neutralizing antibody response after therapy cessation in an HIV-1-infected individual. Montefiori DC; Altfeld M; Lee PK; Bilska M; Zhou J; Johnston MN; Gao F; Walker BD; Rosenberg ES J Immunol; 2003 Apr; 170(7):3906-14. PubMed ID: 12646660 [TBL] [Abstract][Full Text] [Related]
19. HIV-specific CD4+ T cells and viremia: who's in control? Jansen CA; van Baarle D; Miedema F Trends Immunol; 2006 Mar; 27(3):119-24. PubMed ID: 16458605 [TBL] [Abstract][Full Text] [Related]
20. Persistent recognition of autologous virus by high-avidity CD8 T cells in chronic, progressive human immunodeficiency virus type 1 infection. Draenert R; Verrill CL; Tang Y; Allen TM; Wurcel AG; Boczanowski M; Lechner A; Kim AY; Suscovich T; Brown NV; Addo MM; Walker BD J Virol; 2004 Jan; 78(2):630-41. PubMed ID: 14694094 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]